MetLife (NYSE:MET – Get Free Report) and SiriusPoint (NYSE:SPNT – Get Free Report) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation.
Profitability
This table compares MetLife and SiriusPoint’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| MetLife | 6.21% | 25.71% | 0.92% |
| SiriusPoint | 14.93% | 15.89% | 2.87% |
Analyst Ratings
This is a breakdown of recent recommendations and price targets for MetLife and SiriusPoint, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| MetLife | 0 | 1 | 14 | 0 | 2.93 |
| SiriusPoint | 0 | 3 | 3 | 1 | 2.71 |
MetLife presently has a consensus target price of $107.12, indicating a potential upside of 5.94%. SiriusPoint has a consensus target price of $30.67, indicating a potential upside of 16.34%. Given SiriusPoint’s higher possible upside, analysts plainly believe SiriusPoint is more favorable than MetLife.
Risk and Volatility
MetLife has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, SiriusPoint has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500.
Institutional and Insider Ownership
95.0% of MetLife shares are owned by institutional investors. Comparatively, 52.8% of SiriusPoint shares are owned by institutional investors. 0.4% of MetLife shares are owned by company insiders. Comparatively, 12.2% of SiriusPoint shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares MetLife and SiriusPoint”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| MetLife | $80.74 billion | 0.79 | $3.38 billion | $7.67 | 13.18 |
| SiriusPoint | $3.35 billion | 0.91 | $459.60 million | $4.11 | 6.41 |
MetLife has higher revenue and earnings than SiriusPoint. SiriusPoint is trading at a lower price-to-earnings ratio than MetLife, indicating that it is currently the more affordable of the two stocks.
Summary
MetLife beats SiriusPoint on 9 of the 15 factors compared between the two stocks.
About MetLife
MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.
About SiriusPoint
SiriusPoint Ltd. is a Bermuda-based global insurer and reinsurer that provides specialty insurance and reinsurance products to businesses and other organizations. Its offerings span areas such as property and casualty, accident and health, and other specialty risks. The company works with brokers, agents, managing general agents and other distribution partners to underwrite risks across a range of markets. Its business serves clients in the United States and internationally, including in Europe and other regions.
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
